Radiopharmaceutical Theranostics Market: How Is the Neuroendocrine...

adicionou um novo artigo Health

2026-05-01 08:35:02 -

Radiopharmaceutical Theranostics Market: How Is the Neuroendocrine Tumor Market Creating the Foundation?

Neuroendocrine tumor (NET) theranostics — the DOTATATE-based diagnostic imaging (68Ga-DOTATATE, Netspot) and therapeutic (177Lu-DOTATATE, Lutathera) creating the first commercially successful theranostic pair — represents the foundational commercial market demonstrating theranostic viability, with the Radiopharmaceutical Theranostics Market reflecting NET theranostics as the proven...

0 Comentários 0 Compartilhamentos 68 Visualizações 0 Anterior